Related Experiment Video
Updated: Feb 3, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Boosting Immunity by Targeting Post-translational Prenylation of Small GTPases
Caroline Robert1, Stéphan Vagner2
1Oncology Department and INSERM U981, Gustave Roussy, France; Université Paris-Sud, Université Paris-Saclay, Villejuif, France.
Abstract:
Diseases leading to immune activation and autoinflammatory phenotypes may provide a reservoir of potentially druggable pathways for optimizing immune adjuvants or boosting antitumor immune responses. Now, Xia et al. report that lipophilic statins or biphosphonates, targeting the mevalonate pathway, act as efficient vaccine adjuvants and synergize with anti-PD1 against cancer.
Insights
Lipophilic statins and biphosphonates targeting the mevalonate pathway enhance vaccine adjuvants. These compounds also synergize with anti-PD1 therapy to improve antitumor immune responses in cancer.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Immune activation and autoinflammatory diseases highlight druggable pathways.
- Optimizing immune adjuvants and antitumor responses are key therapeutic goals.
Purpose of the Study:
- To investigate the potential of targeting the mevalonate pathway for immune modulation.
- To evaluate lipophilic statins and biphosphonates as vaccine adjuvants.
- To assess the synergy of these agents with anti-PD1 therapy in cancer treatment.
Main Methods:
- Utilized lipophilic statins and biphosphonates targeting the mevalonate pathway.
- Assessed their efficacy as vaccine adjuvants.
- Evaluated their synergistic effects with anti-PD1 immunotherapy in preclinical cancer models.
Main Results:
- Lipophilic statins and biphosphonates demonstrated significant adjuvant properties.
- These compounds enhanced immune responses when used as vaccine adjuvants.
- Combined therapy with anti-PD1 showed synergistic antitumor effects.
Conclusions:
- Targeting the mevalonate pathway offers a novel strategy for developing effective vaccine adjuvants.
- Lipophilic statins and biphosphonates represent promising candidates for combination cancer immunotherapy.
- Further research into mevalonate pathway modulation could optimize immune-based cancer treatments.
More Related Videos
10:07Identification of Post-translational Modifications of Plant Protein Complexes
Published on: February 22, 2014
08:12Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins
Published on: January 8, 2018
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...